Clinical Trial: Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to bDMARD or tsDMARD +/- csDMARD Changing Treatment to a bDMARD or tsDMARD Treatment +/- csDMARD
Study Status: Completed
Recruit Status: RECRUITING
Condition: Rheumatoid Arthritis
Study Type: OBSERVATIONAL
Official Title: Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to bDMARD or tsDMARD +/- csDMARD
Brief Summary:
The primary goal of this study is to assess a cfDNA-based blood test using genetic, transcriptomic and/or epigenetic information to help doctors predict the best treatment options for rheumatoid arthritis (RA) patients with inadequate response or intolerance to previous therapies.
Read more